DDW 2023: Esophageal Cancer Action Network “The Future of Innovation in Esophageal Diseases”

Satisfai Health sponsored and Satisfai Health CEO and Founder Dr. Michael Byrne, VP, Medical Affairs Dr. Nasim Parsa, and VP Business Development Ben Brzezynski participated in “The Future of Innovation in Esophageal Diseases”: From GERD to Esophageal Cancer event at DDW 2023. 

Hosted by Northwestern Medicine Division of Gastroenterology and Esophageal Cancer Awareness Network (ECAN), the event assembled physician and industry experts and stakeholders to discuss the current state of innovation in esophageal diseases and gaps that need to be addressed in Innovation Thinktank panel discussions. 

“Having the who’s who from academia and industry in one room created great collaborative opportunities for this very important disease state. We strongly believe that Artificial Intelligence will play a key role in improving the management of Esophageal Cancer. Congratulations to Mindy Mintz Mordecai and Sri Komanduri for putting this incredible event together.” – Dr Michael Byrne 

Previous
Previous

DDW 2023: AI Models for Barrett’s & Early Esophageal Cancer

Next
Next

Satisfai Health Adds Chief Strategy Officer and VP of Business Development